Thioridazine hydrochloride
-
Thioridazine hydrochloride
structure -
-
CAS No:
130-61-0
-
Formula:
C21H26N2S2.ClH
-
Chemical Name:
Thioridazine hydrochloride
-
Synonyms:
10H-Phenothiazine,10-[2-(1-methyl-2-piperidinyl)ethyl]-2-(methylthio)-,hydrochloride (1:1);Phenothiazine,10-[2-(1-methyl-2-piperidyl)ethyl]-2-(methylthio)-,monohydrochloride;10H-Phenothiazine,10-[2-(1-methyl-2-piperidinyl)ethyl]-2-(methylthio)-,monohydrochloride;Phenothiazine,10-[2-(1-methyl-2-piperidyl)ethyl]-2-(methylthio)-,hydrochloride;Mellaril hydrochloride;2-Methylmercapto-10-[2-(N-methyl-2-piperidyl)ethyl]phenothiazine hydrochloride;10-[3-(1-Methyl-2-piperidyl)ethyl]-2-(methylthio)phenothiazine hydrochloride;Thioridazine hydrochloride;Melleril;Mellaril;Melleril (tablet);Orsanil;Stalleril;Aldazine;Ridazin;Novoridazine;Melleretten;Mallorol;NSC 186060;Thioril;Thiozine;10-[2-(1-Methylpiperidin-2-yl)ethyl]-2-(methylsulfanyl)-10H-phenothiazine hydrochloride;107388-89-6
- Categories:
-
CAS No:
Description
Thioridazine is an antipsychotic drug, used in the treatment of schizophrenia and psychosis, shows D4 selectivity or serotonin antagonism.
Thioridazine hydrochloride is a hydrochloride. It has a role as a first generation antipsychotic and a geroprotector. It contains a thioridazine.|A phenothiazine antipsychotic used in the management of PHYCOSES, including SCHIZOPHRENIA.
Characteristics
57.1
6.69050
White to off-white solid.
158-160 °C
515.7°C at 760 mmHg
265.7ºC
soluble in water (75 mM), DMSO (100 mM), chloroform, ethanol, and methanol.
Desiccate at RT
9.65E-11mmHg at 25°C
185 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]
Safety Information
Ⅲ
9
UN30779/PG3
22-36/37/38-50/53
26-36-60-61
SP2275000
Xn,N
P301 + P312 + P330-P305 + P351 + P338
H302-H315-H319-H335-H410
|Warning|H302 (97.87%): Harmful if swallowed [Warning Acute toxicity, oral]|P261, P264, P270, P271, P273, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P312, P321, P330, P332+P313, P337+P313, P362, P391, P403+P233, P405, and P501|Aggregated GHS information provided by 47 companies from 8 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Drug Information
Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)|Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)
Aldazine
Thioridazine hydrochloride Use and Manufacturing
To a solution of 6f (200 mg, 0.371 mmol) in THF (10 mL, 100 mmol) at 0°C was added 2.0 M lithium aluminum hydride in THF (0.278 mL, 0.557 mmol). The reaction was warmed to room temperature and then heated at 50°C for 18 hours. At that time the reaction was cooled to 0°C and water, 1M sodium hydroxide and water were added. The mixture was stirred overnight and then filtered through a pad of Celite. The filtrate was concentrated under reduced pressure and the remaining residue purified by flash chromatography using 0-5percent methanol in DCM to afford the desired product (36 mg, 26percent) as a colorless oil. This oil was dissolved in ethanol and IM HCI, concentrated under reduced pressure and then concentrated from ethyl acetate twice to afford 7f as a white solid in quantitative yield.Chiral HPLC retention time: 12.85 min. NMR (400 MHz, MeOD) δ (ppm) = 1.48-1.58 (m, 2H), 1.70-2.10 (m, 6H), 2.51 (s, 3H), 2.69 (s, 3H), 2.97-3.17 (m, 2H), 3.37-3.47 (m, IH), 4.05-4.19 (m, 2H), 6.92-6.96 (m, 2H), 7.00-7.04 (m, IH), 7.08-7.10 (m, I H), 7.12-7.14 (m, IH), 7.20-7.23 (m, IH), 7.25- 7.29 (m, I H); MS (ESI+) for C21H26N2S2 m/z 371 (M+H) In an analogous manner, 6s (220 mg, 0.408 mmol) provided 7s (29 mg, 19percent) as a colorless oil. This oil was dissolved in ethanol and IM HCI, concentrated under reduced pressure and then concentrated from ethyl acetate twice to afford 7s as a white solid in quantitative yield.Chiral HPLC retention time: 12.1 1 min. NMR (400 MHz, MeOD) δ (ppm) - 1.48-1.58 (m, 2H), 1.70-2.10 (m, 6H), 2.51 (s, 3H), 2.69 (s, 3H), 2.97-3.17 (m, 2H), 3.37-3.47 (m, 1H), 4.05-4.19 (m, 2H), 6.92-6.96 (m, 2H), 7.00-7.04 (m, III), 7.08-7.10 (m, 1H), 7.12-7.14 (m, 1H), 7.20-7.23 (m, IH), 7.25- 7.29 (m, 1H); MS (ESI+) for C21H26N2S2 mtz 371 (M+H)
Thioridazine HCl is a dopamine receptor blocker and antipsychotic.It is the parent compound of sulforidazine and mesoridazine. This compound has been reported to bind strongly to dopamine receptors on cancer stem cells and cause differentiation leaving normal cells alone (see Can. Chem. News 12 July/August 2012).
Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients
Computed Properties
Molecular Weight:407.0
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:4
Rotatable Bond Count:4
Exact Mass:406.1304189
Monoisotopic Mass:406.1304189
Topological Polar Surface Area:57.1
Heavy Atom Count:26
Complexity:432
Undefined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes
Drug Function and Efficacy
This product is a phenothiazine antipsychotic. Its antipsychotic effect is mainly due to blocking dopamine receptors in the brain. It has a weak effect on dopamine receptors in the extrapyramidal system and the body temperature center, and its sedative effect is also weak.
Registered Holders
-
TRIFARMA SPA
Active
Brazil
-
Hunan Dongting Pharmaceutical Co., Ltd.
Active
China
-
PFC ITALIANA SRL DIV ALFA CHEMICALS ITALIANA
Inactive
United States
Recommended Suppliers of Thioridazine hydrochloride
-
CN
5 YRS
Business licensedTrader Supplier of Intermediates,Building blocks,API,Silicones,Peptides,Lab chemicals,Biochemicals,Pharmaceuticals,Screening Compounds,Food Additives -
CN
3 YRS
Business licensedTrader Supplier of vitaminInquiryCAS No.: 130-61-0Grade: Pharmaceutical GradeContent: 99% -
CN
5 YRS
Business licensedTrader Supplier of PVC resin,pvc paste resin,melamineInquiryCAS No.: 130-61-0Grade: Industrial GradeContent: 99%
Learn More Other Chemicals
-
4H-1-Benzopyran-4-one, 2-[4-[3-(dibutylamino)propoxy]-3,5-dimethylbenzoyl]-, hydrochloride (1:1)
67652-33-9
-
Cyclopropanecarboxylic acid, 1-amino-2-ethenyl-, ethyl ester, hydrochloride (9CI)
681807-60-3
-
CYCLOPENTYL-(3,4,5-TRIMETHOXY-BENZYL)-AMINE HYDROCHLORIDE
1052525-88-8
-
2-Cyclopropylbenzenemethanamine hydrochloride Formula
118184-64-8
-
Des[4-(2-cycloproylMethoxy)] Betaxolol Hydrochloride Formula
464877-45-0
-
Ethanamine, 2-(decylthio)-, hydrochloride (1:1) Formula
36362-09-1
-
4,7-Dichloro-2-propylquinoline hydrochloride Structure
1204812-22-5
-
6,7-Dichloro-4-hydrazino-2-methylquinoline hydrochloride Structure
1170377-12-4
-
What is 2,8-Diazaspiro[4.5]decan-1-one, 2-[(4-bromophenyl)methyl]-, hydrochloride (1:1)
832710-56-2
-
What is 6,7-Dichloro-4-hydrazinoquinoline hydrochloride
1171843-02-9